CSPC Pharmaceutical Group Awarded Grand Prize for National Corporate Culture Excellence

From December 2 to 3, the 16th National Corporate Culture Achievements Awards Ceremony and the Annual National Corporate Culture Conference, hosted by the China Enterprise Confederation and the China Association of Entrepreneurs, was held in Qingdao, Shandong. The conference announced the 16th National Corporate Culture Achievements.，CSPC Honored with the "Special Prize for Corporate Culture Achievements in China" Highest Honor, becoming the first to obtainThe award-winning enterprise in Hebei Province, alsoWithin China's pharmaceutical industryThe first company to receive this award.

The theme of this year's corporate culture annual conference is "Cultivating Outstanding Chinese-characteristic Corporate Culture and Strengthening and Expanding Chinese Enterprise Brands" for cultural exchange and discussion, vividly showcasing Chinese enterprises' cutting-edge exploration in deeply rooting cultural foundations and empowering high-quality development under the guidance of Xi Jinping's cultural thought. A total of 429 national corporate culture achievements were reviewed and approved at this release, including 13 special achievements and first-class achievements.145 items, Second-class Achievements271 itemsThe National Excellent Achievements in Corporate Culture is an award project that has been approved and retained by the central nine ministries after adjustments to evaluations, benchmarking, and commendations. It is also the only retained award project in the field of corporate culture in China.

CSPC's award-winning achievements this time fully demonstrate the company'sWenA new vision of synchronization with corporate and industry development.After years of accumulation and iteration,CSPC Corporate CultureStandBy inheriting and innovating, CSPC has established a core conceptual system centered on the mission of "Making Good Medicines for China to Benefit the World," encompassing CSPC's vision, core values, and a self-portrait of CSPC employees. At the same time, it has built a comprehensive cultural framework covering dimensions such as management standards, employee professional behavior guidelines, professional red lines, and social responsibility. Through creating corporate cultural activities, improving cultural institutional safeguards, and strengthening the dissemination and implementation of ideas, employees are guided to deeply integrate corporate culture into their thoughts and practices, ultimately transforming it into the company’s core competitiveness.

Relying on the positive guidance of corporate culture, all employees of the group have united their efforts and worked with one heart towards a common goal, stimulating a surge of innovative momentum. The group's independent research and development capabilities have continued to rise. The group has built eight major technology platforms including nanomedicine formulations, mRNA, ADC, and cell therapy, with more than 200 innovative drug and innovative formulation projects currently under development. In 2025, the group established a strategic R&D cooperation agreement with global biopharmaceutical leader AstraZeneca on an AI-driven dual-engine high-efficiency drug discovery platform. Through diverse commercial collaborations, the group is committed to promoting Chinese innovative pharmaceutical companies in upgrading from "product output" to "technology platform output" and gradually evolving from "technology licensors" to "global co-developers."

Looking ahead, CSPC will continue to deepen the implementation of its core values of "openness and inclusiveness, harmony and friendliness, diligence and pragmatism, fairness and integrity, cooperation and sharing," promoting their deep integration into professional management, grassroots practice, and employees' daily behavior. By fully unleashing the strong empowerment role of corporate culture in building development consensus, stimulating internal motivation, and enhancing operational efficiency, it will comprehensively boost the enterprise's management level to achieve a leapfrog rise, continuously injecting robust new momentum into the high-quality economic and social development.